| Literature DB >> 18510523 |
P H B Bolton-Maggs1, D Lillicrap, J Goudemand, E Berntorp.
Abstract
Although von Willebrand disease (VWD) is now well-described, many facets of diagnosis and management continue to be debated. The diagnosis of type 1 disease can be difficult but recent genetic analyses help to distinguish many factors which can influence von Willebrand factor (VWF) levels and bleeding phenotype. Type 2 disease (functional abnormalities) includes a particularly interesting group of disorders with faulty binding between VWF and FVIIIC (Normandy) where treatment methods need careful consideration. Type 3 VWD is the most severe form of VWD and a new international study is underway to examine the use of prophylaxis.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18510523 DOI: 10.1111/j.1365-2516.2008.01713.x
Source DB: PubMed Journal: Haemophilia ISSN: 1351-8216 Impact factor: 4.287